🚀 go-pugleaf

Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (September 1, 2012) – Revue de presse (1 septembre 2012)


Breast Cancer Drug Might Help Men on Prostate Cancer Therapy
Study found tamoxifen cut some side effects that could discourage men
from seeking treatment.
In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/08/28/breast-cancer-drug-might-help-men-on-prostate-cancer-therapy

Breast Cancer Drug May Harm the Heart More Than Thought‎‎
Analysis finds increased risk of cardiac problems with Herceptin in
real-world setting.
By Kathleen Doheny. In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/08/30/breast-cancer-drug-may-harm-the-heart-more-than-thought

New prostate cancer study clouds PSA debate
A new study suggests men with advanced prostate cancer may live longer
in the "PSA era" than they did before the screening test began to gain
a foothold in the early 1990s.
By Frederik Joelving. In Reuters
http://www.reuters.com/article/2012/08/24/us-new-prostate-cancer-idUSBRE87N10S20120824

What Do Cancer Patients Think About Exercise?‎‎ ‎‎
Exercise is encouraged for cancer patients -- even if they are going
through treatments. But a small new study from the Mayo Clinic
suggests that some cancer patients still aren't prioritizing physical
fitness, and their oncologists aren't talking to them about it.
In Huffington Post
http://www.huffingtonpost.com/2012/08/29/cancer-exercise-oncologists-recommendations_n_1837219.html

Exelixis says FDA drops panel talks on thyroid cancer drug‎
Exelixis Inc said U.S. regulators have dropped an advisory panel
discussion on the marketing application for its experimental drug to
treat a rare form of thyroid cancer, sending its shares up 6 percent
after market.
In Reuters
http://www.reuters.com/article/2012/08/29/us-exelixis-fda-idUSBRE87S1E920120829

Could a cancer drug potentially prevent learning disabilities in some
kids?‎
A drug originally developed to stop cancerous tumors may hold the
potential to prevent abnormal brain cell growth and learning
disabilities in some children, if they can be diagnosed early enough,
a new animal study suggests.
In Medical Xpress
http://medicalxpress.com/news/2012-08-cancer-drug-potentially-disabilities-kids.html

Cancer gene family member functions key to cell adhesion and
migration‎
The WTX gene is mutated in approximately 30 percent of Wilms tumors, a
pediatric kidney cancer. Like many genes, WTX is part of a family. In
this case, WTX has two related siblings, FAM123A and FAM123C. While
cancer researchers are learning more of WTX and how its loss
contributes to cancer formation, virtually nothing is known of FAM123C
or FAM123A, the latter of which is a highly abundant protein within
neurons, cells that receive and send messages from the body to the
brain and back to the body
In Medical Xpress
http://medicalxpress.com/news/2012-08-cancer-gene-family-member-functions.html



Cancer : et si on le traitait à l’aide du VIH ?‎
Comment combattre le cancer, l’un des pires fléaux de l’humanité ? Des
scientifiques suggèrent d’utiliser un autre de nos plus féroces
ennemis : le VIH. Ou plus précisément l'une des protéines qui lui
permet de se multiplier autant...
Dans Futura-Sciences
http://www.futura-sciences.com/fr/news/t/medecine/d/cancer-et-si-on-le-traitait-a-laaide-du-vih_40817/

Cancer : une molécule découverte‎‎‎‎ ‎‎
Une molécule susceptible d'agir contre les métastases, par le biais
d'un nouveau mécanisme, vient d'être identifiée par des chercheurs,
mais il faudra encore plusieurs années avant d'espérer passer aux
premiers tests cliniques, précisent-ils.
Dans Le Figaro
http://www.lefigaro.fr/flash-actu/2012/08/28/97001-20120828FILWWW00597-cancer-une-molecule-decouverte.php

La prévention au coeur du Congrès mondial sur le cancer, à Montréal
Des spécialistes en provenance de plus de 120 pays participent au 22e
Congrès mondial sur le cancer, qui s'est ouvert au Palais des congrès
de Montréal lundi.
Radio-Canada.ca
http://www.radio-canada.ca/nouvelles/science/2012/08/27/001-congres-mondial-cancer-montreal-2012.shtml

Cancer : une nouvelle molécule porteuse d'espoir‎‎‎‎‎ ‎‎
Des travaux de plus de dix années ont permis de mettre à jour la
molécule "Liminib" qui bloquerait la formation des métastases. Cette
découverte donne de l'espoir aux patients cancéreux et pourrait, dans
un premier temps, servir de traitement alternatif à la chimiothérapie
d'ici quelques années.
Dans Maxisciences
http://www.maxisciences.com/cancer/cancer-une-nouvelle-molecule-porteuse-d-039-espoir_art26326.html






Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix-Corman – InTextoResearch – Baelen  (09/2012)